Polymorphisms in the von Willebrand factor gene are not associated with proliferative retinopathy in non-insulin-dependent diabetes mellitus

被引:5
作者
Beránek, M
Kankova, K
Kolar, P
Znojil, V
机构
[1] Masaryk Univ, Fac Med, Dept Pathophysiol, CZ-66243 Brno, Czech Republic
[2] Brno Fac Hosp, Dept Ophthalmol, Brno, Czech Republic
关键词
proliferative retinopathy; von Willebrand factor; non-insulin-dependent diabetes mellitus; genetic polymorphism;
D O I
10.1159/000065604
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Von Willebrand factor, a multimeric glycoprotein synthesized mainly by endothelial cells, is involved in platelet adhesion and aggregation and has an important role in the process of angiogenesis. Increased levels of von Willebrand factor, reflecting activation or damage of endothelial cells, have been described in association with proliferative diabetic retinopathy (PDR). We investigated the relationships of two polymorphisms (-1793G/C and Thr789Ala) in the von Willebrand factor gene with PDR. Genotypes were detected by polymerase chain reactions with subsequent restrictions with specific endonucleases. Allele frequencies were determined in an association study (n = 371) comprising three groups of subjects (diabetics with and without retinopathy and non-diabetics). Allele frequencies of the -1793G/C and Thr789Ala did not differ between the non-insulin-dependent diabetes mellitus (NIDDM) + PDR and the NIDDM non-PDR groups (p > 0.05). However, a statistically significant difference in allele and genotype frequencies of the -1793G/C was proved between all NIDDM versus nondiabetic subjects (p = 0.024 and 0.0065, respectively) with allele G and genotype GG being significantly more frequent in the NIDDM group. Calculated odds ratio for the GG genotype was 1.20 (95% CI, 0.77-1.86). Although significantly higher plasma von Willebrand factor antigen levels in NIDDM patients with PDR have been described in several studies, our findings indicate that no association exists between the two polymorphisms and PDR. However, the -1793G/C polymorphism might affect the risk of NIDDM. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:327 / 330
页数:4
相关论文
共 11 条
[1]  
[Anonymous], 1991, Ophthalmology, V98, P786
[2]  
Fujiwara Y, 1998, J Atheroscler Thromb, V5, P21
[3]   A single nucleotide polymorphism at nucleotide-1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:Ag levels [J].
Harvey, PJ ;
Keightley, AM ;
Lam, YM ;
Cameron, C ;
Lillicrap, D .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (02) :349-353
[4]  
Heywood DM, 1996, DIABETIC MED, V13, P720, DOI 10.1002/(SICI)1096-9136(199608)13:8<720::AID-DIA176>3.0.CO
[5]  
2-0
[6]   Variation at the von Willebrand Factor (vWF) gene locus is associated with plasma vWF:Ag levels:: Identification of three novel single nucleotide polymorphisms in the vWF gene promoter [J].
Keightley, AM ;
Lam, YM ;
Brady, JN ;
Cameron, CL ;
Lillicrap, D .
BLOOD, 1999, 93 (12) :4277-4283
[7]   Association between high von Willebrand factor levels and the Thr789Ala VWF gene polymorphism but not with nephropathy in type 1 diabetes [J].
Lacquemant, C ;
Gaucher, C ;
Delorme, C ;
Chatellier, G ;
Gallois, Y ;
Rodier, M ;
Passa, P ;
Balkau, B ;
Mazurier, C ;
Marre, M ;
Froguel, P .
KIDNEY INTERNATIONAL, 2000, 57 (04) :1437-1443
[8]  
Lip PL, 2000, INVEST OPHTH VIS SCI, V41, P2115
[9]   PATHOBIOLOGY OF ENDOTHELIAL AND OTHER VASCULAR CELLS IN DIABETES-MELLITUS - CALL FOR DATA [J].
LORENZI, M ;
CAGLIERO, E .
DIABETES, 1991, 40 (06) :653-659
[10]   4-hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response [J].
Minekura, H ;
Kumagai, T ;
Kawamoto, Y ;
Nara, F ;
Uchida, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (02) :557-561